Evaluation of Poly(ADP-ribose) Polymerase Inhibitor, Pamiparib (BGB-290) in Treating Acute Myeloid Leukemia and the Characterization of Its Nanocarrier
Xi Xu(Brigham and Women's Hospital), Dun‐hua Zhou(Sun Yat-sen University), Shaofen Lin(Sun Yat-sen University), Jian Wang(Gansu University of Traditional Chinese Medicine), Tong Tong(Imperial College London), Congmin Liu(Qingdao University)
Cited by 2
Related Papers
A mussel-inspired film for adhesion to wet buccal tissue and efficient buccal drug delivery
|Nature Communications|2021|295
ZIF-8-Modified Multifunctional Bone-Adhesive Hydrogels Promoting Angiogenesis and Osteogenesis for Bone Regeneration
|ACS Applied Materials & Interfaces|2020|258
PEGylated nano-graphene oxide as a nanocarrier for delivering mixed anticancer drugs to improve anticancer activity
|Scientific Reports|2020|203
Elevated frequencies of CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>lo</sup> regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia
|International Journal of Cancer|2010|202
Differential diagnosis of neurodegenerative diseases using structural MRI data
|NeuroImage Clinical|2016|199